An insight into the promoter methylation of PHF20L1 and the gene association with metastasis in breast cancer

被引:3
|
作者
Alfredo Sierra-Ramirez, Jose [1 ]
Sesena-Mendez, Emmanuel [2 ]
Godinez-Victoria, Marycarmen [1 ]
Elen Hernandez-Caballero, Marta [2 ]
机构
[1] Natl Polytech Inst, Med Sch, Grad Sect, Mexico City, DF, Mexico
[2] Meritorious Autonomous Univ Puebla BUAP, Fac Med, Dept Biomed, Puebla, Mexico
来源
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE | 2021年 / 30卷 / 05期
关键词
metastasis; hypomethylation; PHF20L1; miRNA; promoter; 20-LIKE; 1; PHF20L1; DNA METHYLATION; PROTEIN; FAMILY;
D O I
10.17219/acem/133426
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background. Plant homeodomain finger protein 20-like 1 (PHF20L1) is a protein reader involved in epigenetic regulation that binds monomethyl-lysine. An oncogenic function has been attributed to PHF20L1 but its role in breast cancer (BC) is not clear. Objectives. To explore PHF20L1 promoter methylation and comprehensive bioinformatics analysis to improve understanding of the role of PHF20L1 in BC. Materials and methods. Seventy-four BC samples and 16 control samples were converted using sodium bisulfite treatment and analyzed with methylation-specific polymerase chain reaction (PCR). Bioinformatic analysis was performed in the BC dataset using The Cancer Genome Atlas (TCGA) trough data visualized and interpreted in the MEXPRESS website. Methylation, gene expression and survival evaluation were performed with R v. 4.0.2 software. Using multiple bioinformatic tools, we conducted a search for genes co-expressed with PHF20L1, analyzed its ontology and predicted associated miRNAs and miRNA-PHF20L1 networks. The expression and prognostic value of PHF20L1 and co-expressed genes were analyzed. Results. We found demethylation in PHF20L1 promoter in both BC samples and healthy tissues. Data mining with 241 patients demonstrated changes in methylation of promoter regions in basal-like and luminal A subtypes. Expression of the PHF20L1 gene had a negative correlation with methylation. Twelve genes were co-expressed. PHF20L1 is a target of miR96-5p, miR9-5p and miR182-5p, which are involved in proliferation and metastasis. PHF20L1 gene expression was not associated with overall survival (OS), or relapse-free survival (RFS), but was associated with distant metastasis-free survival (DMFS). Conclusions. Our findings showed differences in methylation of PHF20L1 promoter region near TSS and upstream in BC subtypes; its overexpression impacted DMFS. We found that PHF20L1 is targeted by miR96-5p, miR9-5p and miR182-5p, which are involved in proliferation and metastasis, and regulates genes engaged in processes such as alternative splicing.
引用
收藏
页码:507 / 515
页数:9
相关论文
共 50 条
  • [1] Molecular profiling of Tudor domain containing proteins identifies PHF20L1 as a candidate oncogene in breast cancer
    Jiang, Yuanyuan
    Liu, Lanxin
    Shan, Wenqi
    Yang, Zeng-Quan
    CANCER RESEARCH, 2016, 76
  • [2] Conformational Selection in Ligand Recognition by the First Tudor Domain of PHF20L1
    Lv, Mengqi
    Gao, Jia
    Li, Mingwei
    Ma, Rongsheng
    Li, Fudong
    Liu, Yaqian
    Liu, Mingqing
    Zhang, Jiahai
    Yao, Xuebiao
    Wu, Jihui
    Shi, Yunyu
    Tang, Yajun
    Pan, Yueyin
    Zhang, Zhiyong
    Ruan, Ke
    JOURNAL OF PHYSICAL CHEMISTRY LETTERS, 2020, 11 (18): : 7932 - 7938
  • [3] Methyl-lysine readers PHF20 and PHF20L1 define two distinct gene expression-regulating NSL complexes
    Van, Hieu T.
    Harkins, Peter R.
    Patel, Avni
    Jain, Abhinav K.
    Lu, Yue
    Bedford, Mark T.
    Santos, Margarida A.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2022, 298 (03)
  • [4] PHF20L1 mediates PAX2 expression to promote angiogenesis and liver metastasis in colorectal cancer through regulating HIC1
    Zhu, Qing-Chao
    Sun, Jian-Hua
    Liang, Ming-Jun
    Zhang, Zheng-Yun
    Xia, Yang
    BIOLOGICAL CHEMISTRY, 2022, 403 (10) : 917 - 928
  • [5] An association between the matrix metalloproteinase 1 promoter gene polymorphism and lymphnode metastasis in breast cancer
    Przybylowska, K
    Zielinska, J
    Zadrozny, M
    Krawczyk, T
    Kulig, A
    Wozniak, P
    Rykala, J
    Kolacinska, A
    Morawiec, Z
    Drzewoski, J
    Blasiak, J
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2004, 23 (01) : 121 - 125
  • [6] An integrated genomic analysis of Tudor domain-containing proteins identifies PHD finger protein 20-like 1 (PHF20L1) as a candidate oncogene in breast cancer
    Jiang, Yuanyuan
    Liu, Lanxin
    Shan, Wenqi
    Yang, Zeng-Quan
    MOLECULAR ONCOLOGY, 2016, 10 (02): : 292 - 302
  • [7] Promoter methylation assay of SASH1 gene in breast cancer
    Lin Sheyu
    Liu Hui
    Zhang Junyu
    Xu Jiawei
    Wang Honglian
    Sang Qing
    Zhang Hengwei
    Guo Xuhui
    Xing Qinghe
    He Lin
    JOURNAL OF BUON, 2013, 18 (04): : 891 - 898
  • [8] PHF20L1 as a H3K27me2 reader coordinates with transcriptional repressors to promote breast tumorigenesis
    Hou, Yongqiang
    Liu, Wei
    Yi, Xianfu
    Yang, Yang
    Su, Dongxue
    Huang, Wei
    Yu, Hefen
    Teng, Xu
    Yang, Ying
    Feng, Wei
    Zhang, Tao
    Gao, Jie
    Zhang, Kai
    Qiu, Rongfang
    Wang, Yan
    SCIENCE ADVANCES, 2020, 6 (16)
  • [9] Tudor-domain protein PHF20L1 reads lysine methylated retinoblastoma tumour suppressor protein
    Carr, Simon M.
    Munro, Shonagh
    Sagum, Cari A.
    Fedorov, Oleg
    Bedford, Mark T.
    La Thangue, Nicholas B.
    CELL DEATH AND DIFFERENTIATION, 2017, 24 (12): : 2139 - 2149
  • [10] PHD finger protein 20-like protein 1 (PHF20L1) in ovarian cancer: from its overexpression in tissue to its upregulation by the ascites microenvironment
    Dulce Rosario Alberto-Aguilar
    Verónica Ivonne Hernández-Ramírez
    Juan Carlos Osorio-Trujillo
    Dolores Gallardo-Rincón
    Alfredo Toledo-Leyva
    Patricia Talamás-Rohana
    Cancer Cell International, 22